Breaking News

Today
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
Periodicals
Drug distributors sweeten opioid settlement proposal, Bloomberg reports » 13:30
02/20/20
02/20
13:30
02/20/20
13:30
MCK

McKesson

$167.67 /

-0.37 (-0.22%)

, CAH

Cardinal Health

$59.23 /

-0.12 (-0.20%)

, ABC

AmerisourceBergen

$95.07 /

-0.08 (-0.08%)

McKesson (MCK), Cardinal…

McKesson (MCK), Cardinal Health (CAH) and AmerisourceBergen (ABC) sweetened their proposed settlement offer by proposing to pay more than $1B legal fees for states, cities and counties suing over the companies' handling of opioids, Jef Feeley of Bloomberg reports, citing people familiar with the talks. The companies argue that paying the legal fees would free up more money for treatment and other social services taxed by the U.S. opioid crisis, sources told Bloomberg. They are hoping the legal fee overture will garner more support among governmental entities for their offer to pay $18B to resolve more than 2,000 lawsuits, Feeley added. 21 states sent a letter to the companies last week rejecting the offer "as currently structured," the people said.

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Recommendations
Veeva set up for 'clean' beat and raise Q4 report, says Morgan Stanley » 08:55
02/20/20
02/20
08:55
02/20/20
08:55
VEEV

Veeva

$164.19 /

+2.12 (+1.31%)

, IQV

Iqvia

$164.47 /

-0.86 (-0.52%)

Morgan Stanley analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Hot Stocks
Corning, Qualcomm collaborate to develop 5G mmWave infrastructure systems » 08:26
02/20/20
02/20
08:26
02/20/20
08:26
GLW

Corning

$27.95 /

-0.01 (-0.04%)

, QCOM

Qualcomm

$90.60 /

+2.62 (+2.98%)

Corning Incorporated…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Recommendations
Bluebird Bio price target lowered to $128 from $135 at Oppenheimer » 07:30
02/20/20
02/20
07:30
02/20/20
07:30
BLUE

Bluebird Bio

$80.55 /

-7.61 (-8.63%)

Oppenheimer analyst Mark…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Earnings
Syneos Health backs FY20 adjusted EPS view $3.58-$3.78, consensus $3.65 » 06:22
02/20/20
02/20
06:22
02/20/20
06:22
SYNH

Syneos Health

$66.69 /

+0.21 (+0.32%)

Backs FY20 revenue view…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Earnings
Syneos Health reports Q4 adjusted EPS $1.03, consensus $1.01 » 06:21
02/20/20
02/20
06:21
02/20/20
06:21
SYNH

Syneos Health

$66.69 /

+0.21 (+0.32%)

Reports Q4 adjusted…

Reports Q4 adjusted revenue $1.214B, consensus $1.19B.

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Conference/Events
The ASTCT and CIBMTR to hold a joint meeting » 04:55
02/20/20
02/20
04:55
02/20/20
04:55
ABBV

AbbVie

$94.13 /

+0.53 (+0.57%)

, ADPT

Adaptive Biotechnologies

$33.54 /

+1.79 (+5.64%)

, AMGN

Amgen

$223.12 /

+1.38 (+0.62%)

, ATNM

Actinium Pharmaceuticals

$0.25 /

+0.0041 (+1.67%)

, ATRA

Atara Biotherapeutics

$14.75 /

+0.2 (+1.37%)

, AZN

AstraZeneca

$49.31 /

+0.14 (+0.28%)

, BLUE

Bluebird Bio

$80.55 /

-7.61 (-8.63%)

, CDNA

CareDx

$28.17 /

+1.02 (+3.76%)

, CDTX

Cidara Therapeutics

$3.17 /

+0.09 (+2.92%)

, CELG

Bought by BMY

$0.00 /

+ (+0.00%)

, EQ

Equillium

$5.06 /

+0.02 (+0.40%)

, GMDA

Gamida Cell

$4.75 /

-0.01 (-0.21%)

, GSK

GlaxoSmithKline

$43.49 /

-0.06 (-0.14%)

, HUM

Humana

$378.67 /

+6.41 (+1.72%)

, INCY

Incyte

$82.45 /

+3.2 (+4.04%)

, JAZ

Jazz Technologies

$0.00 /

+ (+0.00%)

, KDMN

Kadmon

$5.13 /

+0.285 (+5.88%)

, MGTA

Magenta Therapeutics

$13.11 /

+0.55 (+4.38%)

, MRK

Merck

$82.00 /

-0.46 (-0.56%)

, NVS

Novartis

$97.29 /

+0.08 (+0.08%)

, PFE

Pfizer

$36.23 /

-0.08 (-0.22%)

, RCKT

Rocket Pharmaceuticals

$24.00 /

-1.18 (-4.69%)

, SGEN

Seattle Genetics

$119.90 /

-0.09 (-0.08%)

, SNY

Sanofi

$50.70 /

-0.44 (-0.86%)

, TAK

Takeda Pharmaceutical

$19.02 /

-0.135 (-0.70%)

American Society for…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Yesterday
Downgrade
Bluebird Bio downgraded to Market Perform from Strong Buy at Raymond James » 11:25
02/19/20
02/19
11:25
02/19/20
11:25
BLUE

Bluebird Bio

$82.31 /

-5.85 (-6.64%)

Raymond James analyst…

Raymond James analyst Dane Leone downgraded Bluebird Bio to Market Perform from Strong Buy. and removed his prior $165 price target. In a research note to investors, Leone says his thesis has reached a breaking point where execution issues on the regulatory, clinical and manufacturing side outweigh his support for the innovative drug products and says the Q4 financial report included a number of "extending and ambiguous" timeline updates for the LentiGlobin program. Leone says he could become interested in the story again if he can get comfortable that the management team will deliver on its expected timelines, but thinks the near-term reality is that Bluebird will need significant cash infusions before any reasonable expectation could be made that cash flow from commercial products would offset operating burn in a significant way.

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Options
Largest borrow rate increases among liquid names » 08:45
02/19/20
02/19
08:45
02/19/20
08:45
TLRY

Tilray

$17.10 /

-0.25 (-1.44%)

, ACB

Aurora Cannabis

$1.65 /

+0.09 (+5.79%)

, PYX

Pyxus

$4.33 /

-0.125 (-2.81%)

, IAC

IAC

$237.04 /

-0.85 (-0.36%)

, MCK

McKesson

$167.62 /

-0.44 (-0.26%)

, VHC

VirnetX

$4.77 /

+0.21 (+4.61%)

, SSRM

SSR Mining

$18.71 /

+0.59 (+3.26%)

, KBE

KBW Bank ETF

$45.24 /

-0.57 (-1.24%)

, ICE

IntercontinentalExchange

$96.20 /

-0.635 (-0.66%)

Latest data shows the…

Latest data shows the largest indicative borrow rate increases among liquid option names include: Tilray (TLRY) 104.39% +2.70, Aurora Cannabis (ACB) 139.38% +1.45, Pyxus International (PYX) 20.46% +0.80, IAC (IAC) 0.74% +0.45, McKesson (MCK) 0.58% +0.31, Direxion Daily Bull (TECL) 2.01% +0.29, VirnetX (VHC) 1.40% +0.25, SSR Mining (SSRM) 0.55% +0.18, SPDR S&P Bank (KBE) 0.66% +0.16, and Intercontinental Exchange (ICE) 0.41% +0.16.

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Conference/Events
The ASTCT and CIBMTR to hold a joint meeting » 08:09
02/19/20
02/19
08:09
02/19/20
08:09
ABBV

AbbVie

$93.60 /

-0.47 (-0.50%)

, ADPT

Adaptive Biotechnologies

$31.75 /

+0.29 (+0.92%)

, AMGN

Amgen

$221.74 /

-1.58 (-0.71%)

, ATNM

Actinium Pharmaceuticals

$0.25 /

-0.0132 (-5.09%)

, ATRA

Atara Biotherapeutics

$14.55 /

+0.3 (+2.11%)

, AZN

AstraZeneca

$49.17 /

+1.3 (+2.72%)

, BLUE

Bluebird Bio

$88.16 /

-0.98 (-1.10%)

, CDNA

CareDx

$27.15 /

+0.48 (+1.80%)

, CDTX

Cidara Therapeutics

$3.08 /

+0.1 (+3.36%)

, CELG

Bought by BMY

$0.00 /

+ (+0.00%)

, EQ

Equillium

$5.04 /

+0.06 (+1.20%)

, GMDA

Gamida Cell

$4.76 /

+0.035 (+0.74%)

, GSK

GlaxoSmithKline

$43.55 /

-0.19 (-0.43%)

, HUM

Humana

$372.26 /

-3.815 (-1.01%)

, INCY

Incyte

$79.25 /

+0.83 (+1.06%)

, JAZ

Jazz Technologies

$0.00 /

+ (+0.00%)

, KDMN

Kadmon

$4.85 /

+0.325 (+7.19%)

, MGTA

Magenta Therapeutics

$12.56 /

+0.2 (+1.62%)

, MRK

Merck

$82.46 /

-0.18 (-0.22%)

, NVS

Novartis

$97.21 /

-0.465 (-0.48%)

, PFE

Pfizer

$36.31 /

-0.18 (-0.49%)

, RCKT

Rocket Pharmaceuticals

$25.18 /

+1.18 (+4.92%)

, SGEN

Seattle Genetics

$119.99 /

+1.9 (+1.61%)

, SNY

Sanofi

$51.14 /

+1.21 (+2.42%)

, TAK

Takeda Pharmaceutical

$19.15 /

-0.29 (-1.49%)

American Society for…

American Society for Transplantation & Cellular Therapy (ASTCT) and the Center for International Blood & Marrow Transplant Research (CIBMTR) hold the 2020 TCT: Transplantation & Cellular Therapy Meeting will be held in Orlando on February 19-23.

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.